Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Umeclidinium

A long-acting antimuscarinic inhaled for the maintenance treatment of COPD: approved in the United States in 2013 in a single inhaler with vilanterol, and on its own in 2014. This family brings together the active ingredient, metabolites, labelled standards and other impurities.

Did you know?It is a quinuclidine derivative with a positively charged nitrogen, as the ending -ium suggests: the part of the dose swallowed during inhalation is practically not absorbed from the gut.

Umeclidinium BromideGo to the active ingredient →

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.